ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Impact of low-T and testosterone therapy (TTh) on main health conditions
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 223878" data-attributes="member: 13851"><p><strong><u>Practice points</u></strong></p><p> </p><p><em><strong>*Hypogonadal men should be follow-up and treated in order to decrease not only the</strong></em></p><p><em><strong>symptomatic burden but also the risk of morbidity and mortality</strong></em></p><p><em><strong></strong></em></p><p><em><strong>*It is not clear which is the preferable treatment, thus clinicians should be guided by their own and patient's preferences and by the availability and costs of the therapy in each country</strong></em></p><p> <em><strong></strong></em></p><p><em><strong>*There is evidence of the possible favorable effects of testosterone therapy in hypogonadal men diagnosed with T2DM/MetS on lipidic and glycemic profiles</strong></em></p><p><em><strong></strong></em></p><p><em><strong>*There is evidence of a greater risk of bad clinical outcomes in men with COVID-19-related </strong></em><strong><em>hypogonadism compared to eugonadal men with COVID-19</em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 223878, member: 13851"] [B][U]Practice points[/U][/B] [I][B]*Hypogonadal men should be follow-up and treated in order to decrease not only the symptomatic burden but also the risk of morbidity and mortality *It is not clear which is the preferable treatment, thus clinicians should be guided by their own and patient's preferences and by the availability and costs of the therapy in each country *There is evidence of the possible favorable effects of testosterone therapy in hypogonadal men diagnosed with T2DM/MetS on lipidic and glycemic profiles *There is evidence of a greater risk of bad clinical outcomes in men with COVID-19-related [/B][/I][B][I]hypogonadism compared to eugonadal men with COVID-19[/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Impact of low-T and testosterone therapy (TTh) on main health conditions
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top